Parasitic infections in the blood supply: Assessing and countering the threat

Developments in Biologicals

Volumn 127, Issue , 2007, Pages 17-41

  Wendel, S ^a   Leiby, D A ^b  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b HOLLAND LABORATORY   (United States)

Author keywords

Blood transfusion; Chagas disease; Infectious diseases; Malaria; Parasites

Indexed keywords

BABESIOSIS; BLOOD; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; CONFERENCE PAPER; DISEASE TRANSMISSION; HUMAN; LEISHMANIASIS; MALARIA; PARASITOSIS; TOXOPLASMOSIS; TRYPANOSOMIASIS;

BABESIOSIS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; HUMANS; LEISHMANIASIS; MALARIA; PARASITIC DISEASES; TOXOPLASMOSIS; TRYPANOSOMIASIS;

EID: 34247169899     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (238)

1. Farrugia A: The mantra of blood safety: time for a new tune? Vox Sang 2004; 86: 1-7.
2. Warrell DA, Gilles HA, Gilles HM: Bruce-Chwatt's essential malariology, 4 th Edition. London, UK, Edward Arnold, 2002.
3. Tabor E: Infectious complications of blood transfusion. New York, USA, Academic Press, 1982.
4. WHO: The biology of malaria parasites - Technical Report Series 743, World Health Organization, Geneva, Switzerland, 1987.
5. López-Antuñano FJ, Schmunis G (eds): Diagnosis of malaria. Scientific Publication No 512. Washington DC, USA, Pan American Health Organization, 1990.
6. Wendel S: The protozoal parasites, malaria and chagas' disease, in Linden JV, Bianco C (eds): Blood Safety and Surveillance. Marcel Dekker, Inc. New York, 2003, pp 355-398.
7. Salutari P, Sica S, Chiusolo P, Micciulli G, Plaisant P, Nacci A., Antinori A, Leone G: Plasmodium vivax malaria after autologous bone marrow transplantation: an unusual complication Bone M Transpl 1996; 18: 805-806.
8. Talabiska DG, Komar MJ, Wytock DH, Rubin RA: Post-transfusion acquired malaria complicating orthotopic liver transplantation. Am J Gastroenterol 1996; 91: 376-379.
9. Tran VB, Tran VB, Lin KH: Malaria infection after allogeneic bone marrow transplantation in a child with talassemia. Bone M Transpl 1997; 19: 1259-1260.
10. Thellier M, Lusina D, Guiguen C, Delamaire M: Is airport malaria a transfusion-transmitted malaria risk? Transfusion 2001; 41: 301-302.
11. Woolsey G: Transfusion for pernicious anaemia: two cases. Ann Surg 1911; 53: 132-135.
12. Turc JM: Malaria and blood transfusion, in Westphal RG, Carlson KB, Turc JM (eds): Emerging global patterns in transfusion-transmitted infections. Arlington, VA, USA, AABB, 1990, pp 31-43.
13. International Forum: which are the appropriate modifications of existing regulations designed to prevent the transmission of malaria by blood transfusion, in view of the increasing frequency of travel to endemic areas ? Vox Sang 1987; 52: 138-148.
14. Rouger P: Du paludisme au paludisme post-transfusionnel. Transf Clin Biol 1999; 6: 72-74.
15. Shah S, Filler S, Causer LM, Rowe AK, Bloland PB, Barber AM, Roberts JM, Desai M, Parise ME, Steketee RW: Malaria surveillance, United States, 2002. MMWR 2004; 53 (SS01): 21-34. Also available as www.cdc.gov/mmwr/PDF/ss/ss5301.pdf.
16. Kano S, Kimura M: Trends in malaria cases in Japan. Acta Tropica 2004; 89:271-278.
17. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-217.
18. WHO - World malaria situation in 1990. Weekly Ep. Record 1992; 67: 161-168 (Part I).
19. WHO - World malaria situation in 1990. Weekly Ep. Record 1992; 67: 169-176 (Part II).
20. Alves MJCP, Rangel O, Souza SSAP: Malária na região de Campinas, São Paulo, Brasil, 1980 a 1994. Rev Soc Bras Med Trop 2000; 33: 53-60.
21. Bradley DJ, Warhurst DC, Blaze M, Smith V, Williams J: Malaria imported into the United Kingdom in 1996. Eurosurveillance 1998; 3:40-42
22. Frey-Wettstein M, Maier A, Markwalder K, Münch U: A case of transfusion transmitted malaria in Switzerland. Swiss Med Wkly 2001; 131: 320.
23. Bellmann R, Sturm W, Pechlaner C, Weiss G, Bellman-Weiler R, Wiedermann J, Patsch JR: Imported malaria: Six cases of severe Plasmodium falciparum infection in Innsbruck, Austria, within a period of five weeks (February/March 1999). Wien Klin Wochenschr 2000; 112:453-458.
24. Bruce-Chwatt LJ: Transfusion malaria revisited. Trop Dis Bull 1982; 79: 827-840.
25. Nahlen BL, Lobel HO, Cannon SE, Campbell CC: Reassessment of blood donor selection criteria for the United States travellers to malarious areas. Transfusion 1991; 31:798-804.
26. Shehata N, Kohli M, Detsky A: The cost-effectiveness of screening blood donors for malaria by PCR. Transfusion 2004; 44: 217-228.
27. Mungai M, Tegtmeier G, Chamberland M, Parise M: Transfusion-Transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344: 1973-1978.
28. Kitchen A, Mijovic A, Hewitt P: Transfusion-transmitted malaria: current donor selection guidelines are not sufficient. Vox Sang 2005; 88: 200-201.
29. Fairley NH: Trans R Soc Trop Med Hyg 1947; 40: 621-676.
30. Council of Europe: Guide to the preparation, use and quality assurance of blood components - 2005 (11th edition), available at www.coe.int.
31. Wells L, Ala FA: Malaria and blood transfusion. Lancet 1985; i: 1317-1318.
32. Andrade JCR, Wanderley DMV: Malária induzida no Estado de São Paulo, Brasil. Rev Soc Bras Med Trop 1991; 24: 157-161.
33. Ferreira MV, Camargo LMA, Carvalho ME, Ninomia RT, Garcia LAV, Santos FR: Prevalence and levels of IgG and IgM antibodies against Plasmodium falciparum and P. vivax in blood donors from Rondonia, Brazilian Amazon. Mem Inst Oswaldo Cruz 1993; 88: 263-269.
34. Standards for Blood Banks and transfusion services. Bethesda MD, USA, AABB, 23rd ed, 2005.
35. Purdy E, Perry E, Gorlin J, Jensen K: Transfusion-transmitted malaria: unpreventable by current donor exclusion guidelines? Transfusion 2004; 44:464.
36. Slinger R, Giulivi A, Bodie-Collins M, Hindieh F, St. John R, Sher G, Goldman M, Ricketts M, Kain KC: Transfusion-transmitted malaria in Canada. Can Med Assoc J 2001; 164: 377-379.
37. Roll Back Malaria. World Health Organization (WHO), http://mosquito.who. int/malariacontrol.
38. Sazama K: Prevention of transfusional-transmitted malaria: is it time to revisit the standards (Editorial). Transfusion 1991; 31: 786-788.
39. Custer B, Johnson ES, Sullivan SD, Hazlet TH, Ramsey SD, Hirschler N, Murphy EL, Busch MP: Quantifying losses to donated blood supply due to deferral and miscollection. Transfusion 2004; 44: 1417-1426.
40. Arafat R, Long S, Perry M, Marsh S, Wilson M, Avashia S, Filler S: Probable Transfusion-Transmitted malaria. Houston, Texas, MMWR 2003; 52: 1076-1076.
41. Chiodini PL, Hartley S, Hewitt PE, Barbara JAJ, Lalloo K, Bligh J, Voller A: Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of transfusion-transmitted malaria. Vox Sang 1997; 73:143-148.
42. Soler CP, Gerome P, Soullié B, Tissedre F, Bejan H, Yvetot J, Joussemet M: Comparaison de techniques de depistage des anticorps anti-paludiques utilisées en transfusion. Med Trop 2003; 63: 587-589.
43. Kitchen AD, Lowe PHJ, Lalloo K, Chiodini PL: Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use. Vox Sang 2004; 87: 150-155.
44. Brazilian Ministry of Health, Resolution 153, 2004.
45. Ibhanesebor SE, Otobo ES, Ladipo OA: Prevalence of malaria parasitemia in transfused donor blood in Benin City, Nigeria. Ann Trop Ped 1996; 16: 93-95.
46. Zavizion B, Pereira M, Jorge MM, Serebryanik D, Mather TN, Chapman J, Miller NJ, Alford B, Bzik DJ, Purmal A: Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry. Transfusion 2004; 44: 731-738.
47. Draper CC, Sirr SS: Serological investigation in retrospective diagnosis of malaria. Br J Med 1980; 2: 1575-1576.
48. Assal A, Kauffmann-Lacroix C, Rodier MH, Dardé ML, Houssay D, Jacquemin JL: Comparison de deux techniques de détection des anticorps anti-Plasmodium falciparum: Falciparum-spot IF® (Boimérieux) et Malaria IgG Celisa® (BMD). Résultats préliminaires. Transf Clin Biol 1999; 6: 119-123.
49. Fonseca MO, Pang L, Ávila SLM, Arruk VG, Ferreira AW, Sáez-Alquezar A, Boulos M: Cross-reactivity of anti-Plasmodium falciparum antibodies and HIV tests. Trans Roy Soc Trop Med Hyg 2000; 94: 171-172.
50. Jani IV, Janossy G, Brown DWG, Mandy F: Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis 2002; 2: 243-250.
51. Moody A: Rapid Diagnostic Tests for malaria parasites Clin Microbiol Rev 2002; 15: 66-78.
52. Choudhury N, Jolly JG, Mahajan RC, Dubey ML, Kalra A, Ganguly NK: Selection of blood donors in malaria endemic countries. Lancet 1988; ii: 972-973.
53. Rock EP, Marsh K, Saul SJ, Wellems TE, Taylor DW, Maloy WL, Howard RJ: Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP1, HRP2, and HRP3 in malaria diagnosis of diverse origin. Parasitology 1987; 95: 209-227.
54. Parra ME, Evans CB, Taylor DW: Identification of Plasmodium falciparum Histidine-Rich Protein 2 in the Plasma of Humans with Malaria. J Clin Microbiol 1991; 29: 1629-1634.
55. Taylor DW, Voller A: The development of a simple antigen detection ELISA for Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1993; 87: 29-31.
56. Namsiriponpun V, Wilde, H, Pamsandang P, Tiersansern P: Field study of an antigen-detection ELISA specific for Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1993; 87: 32-34.
57. Davidson N, Woodfield G, Henry S: Malarial antibodies in Auckland blood donors. N Z Med Journal 1999; 112: 181-183.
58. Meier B, Dobeli H, Certa U: Stage-specific expression of aldolase isoenzymes in the rodent malaria parasite Plasmodium bergei. Mol Biochem Parasitol 1992; 52:15-27
59. Piper RC, Vanderjagt DL, Holbrook JJ, Makler M: Malaria lactate dehydrogenase: target for diagnosis and drug development. Ann Trop Med Parasitol 1996; 90:433.
60. World Health Organization (WHO): Malaria Rapid Diagnosis. Making it work. Meeting Report 20-23.01.2003 (RS/2003/GE/05 (PHL)), available at http://mosquito.who.int.
61. De Monbrison F, Gérome P, Chaulet JF, Wallon M, Picot S, Peyron F: Comparative diagnostic performance of two commercial rapid tests for malaria in a non-endemic area. Eur J Clin Microbiol Infect Dis 2004; 23: 784-786.
62. Playford EG, Walker J: Evaluation of the ICT malaria P.f./P.v. and the OptiMal rapid diagnostic tests for malaria in febrile returned travelers. J Clin Microbiol 2002; 40: 4166-4171.
63. Bell D: Malaria Rapid Diagnostic tests: one size may not fit all (letter). Clin Microbiol Rev 2002; 15: 771-772.
64. Craig MH, Bredekamp BL, Vaughan Williams CH, Rossouw EJ, Kelly VJ, Kleinschmidt I, Martineau A, Henry GFJ: Field and laboratory comparative evaluation of ten rapid malaria diagnostic tests. Trans R Soc Trop Med Hyg 2002; 96: 258-265.
65. Seed CR, Kitchen A, Davis TME: The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transf Med Rev 2005; 19: 229-240.
66. Orton SL, Virvos VJ, Williams AE: Validation of selected donor-screening questions: structure, content, and comprehension. Transfusion 2000; 40: 1407-1413.
67. Silvie O, Thellier M, Rosenheim M, Datry A, Lavigne P, Danis M, Mazier D: Potential value of Plasmodium falciparum-associated antigen and antibody detection for screening of blood donors to prevent transfusion-transmitted malaria. Transfusion 2002; 42: 357-362.
68. Vu TT, Phan NT, Le TT, Luong VH, O'Brien E, Morris GE: Screening donor blood for malaria by polymerase chain reaction. Trans R Soc Trop Med Hyg 1995; 89:44-47.
69. De Monbrison F, Angei C, Staal A, Kaiser K, Picot S: Simultaneous identification of the four human Plasmodium species and quantification of Plasmodium DNA load in human by real-time polymerase chain reaction. Trans Royal Soc Trop Med Hyg 2003; 97: 387-390.
70. Barea L, Gonzalez R, Bueno JL, Castro E: Strategy for the acceptance of blood donors coming from malaria areas. Transfusion 2001; 41 (Suppl): 75S.
71. International Forum: Are current measures to prevent transfusion- associated protozoal infections sufficient? Vox Sang 2004; 87: 125-138.
72. Mazza S, Montana A, Benitez C, Juzin E: Transmisión de "Schizotrypanum cruzi" al niño por leche de la madre con enfermedad de Chagas. Publ MEPRA 1936; 28: 41-46.
73. Freitas JLP, Amato V, Sonntag R, Biancalana A, Nussenszweig V, Barreto JG: Primeiras verificacões de transmissão acidental da molestia de Chagas ao homem por transfusão de sangue. Rev Paul Med 1952; 40: 36-40.
74. Nussenzweig V, Sonntag R, Biancalana A, Freitas JLP, Amato Neto V, et al: Ação de corantes tri-fenilmetanicos sobre o Trypanosoma cruzi in vitro. Emprego da Violeta de Genciana na profilaxia da transmissão da Moléstia de Chagas por transfusão de sangue. O
75. Geiseler PJ, Ito JI, Tegtemeier BR, Kerndt PR, Krance R: Fulminant Chagas' disease in bone marrow transplantation. 27th Intersc Conf on Antimicro Agents and Chemoter. Washington, Am Soc for Microbiol (Abstract), 1987, 418.
76. Grant I, Gold JWH, Wittnee M, et al: Transfusion associated acute Chagas' disease acquired in the United States. Ann Intern Med 1989; 111: 849-851.
77. Nickerson P, Orr P, Schoeder MC, Sekla L, Johnson J: Transfusion associated Trypanosoma cruzi infection in a non endemic area. Ann Inter Med 1989; 111: 851-853.
78. Cimo PL, Luper WE, Scouros MA: Transfusion-associated Chagas' disease in Texas: Report of a case. Tex Med 1993; 89: 48-50.
79. Leiby DA, Yund J, Read EJ, Lenes BA, Dodd RY: Risk factors for Trypanosoma cruzi infection in seropositive blood donors. Transfusion 1996; 36 (Suppl 9S): S228.
80. Galel S, Wolles S, Stumpf R: Evaluation of a selective donor testing strategy. Transfusion 1997; 37 (Suppl 9S): S296.
81. Leiby DA, Jensen NC, Fucci MC, Stumpf RJ: Prevalence of Trypanosoma cruzi antibodies in a blood donor population at low risk. Transfusion 1997; 37 (Suppl 9S): S297.
82. Schmunis GA: American Trypanosomiasis as a Public Health Problem, in PAHO: Chagas' disease and the Nervous System. Washington DC, USA, Scientific Publication, 1994, vol 547, pp 3-29.
83. Umezawa ES, Stolf AMS, Corbett CEP, Shikanai-Yasuda MA: Chagas'disease. Lancet 2001; 357: 797-799.
84. Prata A: Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 1: 92-100.
85. World Health Organization (WHO): Chagas disease. TDR strategic direction, February, 2002, http://www.who.int/tdr/diseases/chagas/direction.htm.
86. Hayes RJ, Schofield CJ: Estimación de las tasas de incidencia de infecciones y parasitosis crónicas a partir de la prevalencia: La enfermedad de Chagas en America Latina. Bol Of Sanit Panam 1990; 108: 308-316.
87. World Bank: The World Bank Development Report 1993. Investing in Health. World development indicators. Washington, University Press, 1993.
88. Silveira AC: Introdução, in O controle da doença de Chagas nos países do Cone Sul da América. História de uma Iniciativa Internacional 1991/2001, OPS, 2002, pp 16-41.
89. Moncayo A: Chagas'disease. Tropical disesase Research. Progress 1991-92. Eleventh Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Worl Health Organization, Geneva, 1993, pp 67-75.
90. Panamerican Health Organization: I Reunión de la Comisión Intergubernamental del Cono Sur para la Eliminación de T. infestans y la Interrupción de la Transmision de la Tripanosomiasis Americana Transfusional, OPS, 1992 OPS/HCP/HCT/PNSP/92.18.
91. Panamerican Health Organization: Va. Reunión de la Comisión Intergubernamental (CI) de la Iniciativa Andina de Control de la Transmisión Vectorial y Transfusional de Chagas - Guyaquil, Ecuador, Mayo 2003 - OPS, 2003 (available at http://www.paho.org/Spanish/AD/DPC/CD/dch-v- inicandina.htm).
92. Panamerican Health Organization: Iniciativa del Cono Sur. VI Reunión Intergubernamental para la eliminación de Triatoma infestans y la interrupción de la tripanosomiasis americana por transfusión. Documento OPS/HPC/HCT 98/102, 1997, 83 p.
93. World Health Assembly: Resolution WHA.51.14, Geneva, 1998.
94. Wendel S, Brener Z, Camargo M, Rassi A (eds): Chagas disease (American Trypanosomiasis): its impact on transfusion and clinical medicine. ISBT, Brasil '92, SBHH, 1992.
95. Miles MA: Further enzymic characters of Trypanosoma cruzi and their evaluation for strain identification. Trans Roy Sci Trop Med Hyg 1980; 74:221-237.
96. Miles MA: The epidemiology of South American Trypanosomiasis, biochemical and immunological approaches and their relevance to control. Trans Roy Soc Trop Med Hyg 1983; 77: 5-23.
97. Morel C, Chiari E, Plessman-Camargo E, Mattel D, Romanha AJ, Simpson L: Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proc Natl Acad Sci USA 1980; 77: 6810-6814.
98. Avila H, Gonçalves AM, Nehme NC, Morel CM, Simpson L: Schizodeme analysis of Trypanosoma cruzi stocks from South and Central America by analysis of PCR-amplified minicircle variable region sequences. Molec Biochem Parasitol 1990; 42:175-188.
99. El-Sayed MM, Myler PJ, Bartholomeu DC, et al: The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005; 309: 409-415.
100. Chocair PR, Sabbaga E, Amato Net V, Shiroma M, Goes GM: Transplante de rim: nova modadlidade de transmissão da doença de Chagas. Rev Med Trop S Paulo 1981; 23: 282-282.
101. Ferraz AS, Figueiredo JFC: Transmission of Chagas'disease through transplanted kidney: ocurrence of the cute form of the disease in two recipients from the same donor. Rev Inst Med Trop S Paulo 1993; 35: 461-463.
102. Valente SAS, Valente VC, Fraiha Neto H: Considerations on the Epidemiology and Transmission of Chagas Disease in the Brazilian Amazon. Mem Inst Oswaldo Cruz 1999; 94 (Suppl I): 395-398.
103. Dias JCP, Brener Z: Chagas' disease and blood transfusion. Mem Inst Oswaldo Cruz 1984; 79: 139-147.
104. Schmuñis GA: Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and non endemic countries. Transfusion 1991; 31: 547-557.
105. Wendel S, Gonzaga AL: Chagas disease and blood transfusion: a new world problem? Vox Sang 1993; 64: 1-12.
106. Wendel S: Doença de Chagas Transfusional, in Dias JCP, Coura JR (eds): Clínica e terapêutica da Doença de Chagas. Rio de Janeiro, Brasil, Editora Fiocruz, 1997, pp 411-427.
107. Appleman MD, Shulman IA, Saxena S, Kirchhoff LV: Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi. Transfusion 1993; 33: 61-64.
108. Barea L, Cañavate C, Flores M, Rodriguez M, Bueno JL, Gozales R, Gárate T, Castro E: Seroprevalence of anti-Trypanosoma cruzi in blood donors coming from Chagas's diasease endemic countries. Vox Sang 2004; 87 (Suppl 3): Abstract W 01.03.
109. Sullivan TS: Viability of Trypanosoma cruzi in citrated blood stored at room temperature. J Parasitol 1944; 30: 200.
110. Weinman D, MacAlister J: Prolonged storage of human pathogenic protozoa with conservation of virulence. Am J Hyg 1947; 45: 102-121.
111. Filardi LS, Brener Z: Cryopreservation of Trypanosoma cruzi bloodstream forms. J Protozool 1975; 22: 398-401.
112. Schlemper Jr BR: Estudos experimentais de quimioprofilaxia de transmissão da doença de Chagas por transfusão sangüínea. Rev Patol Trop 1978; 7: 55-111.
113. Cerisola JA, Rabinovich A, Alvarez M, Di Corleho CA, Pruneda J: Enfermedad de Chagas y la transfusion de sangre. Bol of Sanit Panam 1972; 63: 203-221.
114. Lorca M, Lorca J, Child R, Atias A, Conales M, et al: Prevalencia de la infección por Trypanosoma cruzi en pacientes politransfundidos. Rev Med Chile 1988; 116: 112-116.
115. Villalba R, Fornés G, Alvarez MA, Román J, Rubio V, Fernandez M, Garcia JM, Viñals M, Torres A: Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Inf Dis 1992; 14: 594-595.
116. Kirchhoff LV: Trypanosoma cruzi: a new threat to our blood transfusion supply (Editorial). Ann Intern Med 1989; 111: 773-775.
117. Kirchhoff LV: American trypanosomiasis (Chagas disease). A tropical disease now in the United States. N Engl J Med 1993; 329: 639-644.
118. Kirchhoff LV, Neva FA: Chagas' disease in Latin American immigrants. JAMA 1985; 254: 3058-3060.
119. Milei J, Mautner B, Storino R, Sanchez, JÁ, Ferrans VS: Does Chagas'disease exist as an undiagnosed form of cardiomyopathy in the United States? (Editorial) Am H Journ 1992; 123: 1732-1735.
120. Schmunis GA, Cruz JR: Safety of the blood supply in Latin America. Clin Microbiol Rev 2005; 18:12-29.
121. Wendel S: Chagas disease: an old entity in new places (Editorial). Int J Art Organs 1993; 16: 117-119.
122. Coura JR, Nogueira ES, Silva JR: Indices de transmissão da doença de Chagas por transfusão de sangue de doadores na fase crônica da doença. O Hospital 1966; 69: 115-122.
123. Rohwedder RW: Infección chagásica en doadores de sangre y las probabilidades de transmitirla por medio de la transfusion. Bol Chile Parasitol 1969; 24: 88-93.
124. Zuna H, Recacoechea M, Bermudez H, Romero A, Castedo J: Transmissión de la enfermedad de Chagas por via transfusional en Santa Cruz de la Sierra, Bolivia. Bol Inf CENENTROP 1979; 5:49-56.
125. Luquetti AO. - Diagnóstico etiológico da doença de Chagas. Rev Pat Trop 2000; 29 (supl.): 145-149.
126. Wendel S: Risco residual da transmissão da infecção por Trypanosoma cruzi por via transfusional no Brasil, PhD Thesis. Faculdade de Medicina da Universidade de São Paulo, Brazil, USP/FM/SBD-20/05, 2005.
127. Wendel S, Yasuda MAS, Silva GR: Residual risk for Trypanosoma cruzi transmission by transfusions in Brazil. Transfusion 2005; Suppl Abstract S50-030J.
128. Wendel S: Blood Banking preventive approaches for Chagas disease. Mem Inst Oswaldo Cruz 1993; 88 (suppl.): 59-60.
129. Zicker F, Martelli CMT, Andrade ALLS, Silva SA: Trends of T. cruzi infection based on data from blood bank screening. Rev Inst Med Trop S Paulo 1990; 39: 132-137.
130. Wendel S, Biagini S: Absence of serological surrogate markers for Trypanosoma cruzi infected blood donors. Vox Sang 1995; 69: 44-49.
131. Docampo Moreno SNJ, Muniz RP, Cruz FS, Mason RP: Light-enhanced free radical formation and Trypanocidal action of Gentian Violet (Crystal Violet). Science 1983; 220: 1292-1295.
132. Docampo R, Moreno SNJ: Free radicals metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Rev Inf Dis 1984; 6: 223-238.
133. Docampo R, Gadelha FR, Moreno SNJ, Benaim G, Hoffman ME, Vercasi AE: Disruption of Ca + 2 homeostasis in Trypanosoma cruzi by crystal violet. J Eur Microbiol 1993; 40: 311-316.
134. Souza HM: The present state of chemoprophylaxis in transfusional Chagas' disease (Editorial) Rev Soc Bras Med Trop 1989; 22:1-3.
135. Schlemper Jr BR: Estudos experimentais de Quimio-profilaxia de transmissão da doença de Chagas por transfusão sangüínea. Rev Pat trop 1978; 7:55-111.
136. Van Voorhis WC, Barrett LK, Eastman RT, Alfonso R, Dupuis K: Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003; 47: 475-479.
137. Chiari E: Diagnostic tests for Chagas disease, in Wendel S, Brener Z, Camargo ME, Rassi A (eds): Chagas disease (American Trypanosomiasis): Its impact on transfusion and clinical medicine. São Paulo, ISBT Brazil'92, pp 153-164.
138. Wendel S, Takaoka DT, Fachini R, Oliveira LC, Lima LP, Tibbals MA, Leiby DA: Serological screening tests for Trypanosoma cruzi antibodies: the role of supplemental methods. Transfusion 1997; 37 (suppl): S298.
139. Avila HA, Sigman DS, Cohen LM, Millikan RC, Simpson L: Polymerase Chaín reaction of Tripanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas disease. Mol Biochem Parasitol 1991; 48: 211-222.
140. Avila H, Pereira JB, Thiemann O, Paiva E, Degrave W, Morel CM, Simpson L: Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J Clin Microbiol 1993; 31: 2421-2426.
141. Wincker P, Britto C, Pereira JB, Cardoso MA, Oelemann W, Morel C: Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am J Trop Med Hyg 1994; 51: 771-777.
142. Britto C, Cardoso MA, Ravel C, Santoro A, Borges Pereira J, Coura JR, Morel CM, Wincker P: Trypanosoma cruzi: parasite detection and strain discrimination in chronic chagasic patients from Northeastern Brazil using PCR amplification of kinetoplast DNA and nonradioactive hybridization. Exp Parasitol 1995; 81: 462-471.
143. Gomes ML, Galvão LMC, Macedo AM, Pena SDJ, Chiari E: Chagas'disease diagnosis: comparative analysis of parasitologic, molecular and serologic methods. Am J Trop Med Hyg 1999; 60: 205-210.
144. Souto RP, Zingales B : Sensitive detection and strain classification of Trypanosoma cruzi by amplification of a ribosomal RNA sequence. Mol Biochem Parasital 1993; 62: 45-52.
145. Clark AK, Kovtunovych G, Kandikar S, Lal S, Stryker GA: Cloning and expression analysis of two novel paraflagellar rod domain genes found in Trypanosoma cruzi. Parasital Res 2005; 96: 312-320.
146. Brenière SF, Bosseno MF, Revolta S, Rivera MT, Carlier Y, Tibayrenc M : Direct identification of Trypanosoma cruzi natural clones in vectors and mammalian hosts by polymerase chain reaction amplification. Am J Trop Med Hyg 1992; 46: 335-341.
147. Britto C, Cardoso MA, Ravel C, Santoro A, Borges Pereira J, Coura JR, Morel CM, Wincker P : Trypanosoma cruzi : parasite detection and strain discrimination in chronic chagasic patients from Northeastern Brazil using PCR amplification of kinetoplast DNA and nonradioactive hybridization. Exp Parasital 1995; 81: 462-471.
148. Silber AM, Búa J, Porcel BM, Segura EL, Ruiz AM : Trypanosoma cruzi : specific detection of parasites by PCR in infected humans and vectors using a set of primers (BP1/BP2) targeted to a nuclear DNA sequence. Exp Parasital 1997; 85:225-232.
149. Zingales B, Souto RP, Mangia RH, Lisboa CV, Campbell DA, Coura JR, Jansen A, Fernandes O : Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and miniexon gene sequences. Intern J Parasital 1998; 28: 105-112.
150. Antaz PRZ, Medrano-Mercado N, Torrico F, Ugarte-Fernandez R, Gómez F, Oliveira RC, Chaves ACL, Romanha AJ, Araújo-Jorge TC : Early, intermediate, and late acute stages in Chagas' disease : a study combining anti-galactose IgG, specific serodiagnosis, and polymerase chain reaction analysis. Am J Trop Med Hyg 1999; 61: 308-314.
151. Lages-Silva E, Crema E, Ramirez LE, Macedo AM, Pena SD, Chiari E: relationship between Trypanosoma cruzi and human chagasic megaesophagus : blood and tissue parasitism. Am J Trop Med Hyg 2001; 65: 435-441.
152. Marcon GEB, Andrade PD, Albuquerque DM, Wanderley JS, Almeida EA, Guariento ME, Costa SCB : Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn Microbiol Infect Dis 2002; 43: 39-43.
153. Galvão LMC, Chiari E, Macedo AM, Luquetti AO, Silva SA, Andrade ALSS : PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy. J Clin Microbiol 2003; 41: 5066-5070.
154. Virreira M, Torrico F, Truyens C, Alonso-Vega C, Solano M, Carlier Y, Svoboda M: Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg 2003; 68: 574-582.
155. Vera-Cruz JM, Magallón-Gastelum E, Grijalva G, Rincón AR, Ramos-García C, Armendáriz-Boninda J : Molecular diagnosis of Chagas disease and use of an animal model to study parasite tropism. Parasitol Res 2003; 89: 480-486.
156. Salomone OA, Basquiera AL, Sembaj A, Aguerri AM, Reyes ME, Omelianuk M, Fernández RA, Enders J, Palma A, Barrai JM, Madoery RJ : Trypanosoma cruzi in persons without serologic evidence of disease, Argentina. Emerg Infect Dis 2003; 9: 1558-1562.
157. Castro AM, Luquetti AO, Rassi A, Rassi GG, Chiari E, Galvão LMC : Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol Res 2002; 88: 894-900.
158. Cura E, Wendel S (eds): Manual de Procedimientos de Control de Calidad para los Laboratories de Serologia de los Bancos de Sangre. PAHO/HPC/HPT/94.21, Washington DC USA, 1994.
159. Ferreira AW: Serological diagnosis: Tests for Chagas disease serodiagnosis: a review, in Wendel S, Brener Z, Camargo ME, Rassi A (eds) : Chagas disease (American Trypanosomiasis) : Its impact on transfusion and clinical medicine. São Paulo, ISBT Brazil'92, pp 179-193.
160. Voller A, Draper C, Bidwell DE, Bartlett A: A micro-plate enzyme-linked immunosorbent assay (ELISA) for Chagas disease. Lancet 1975; 1: 426-429.
161. Wendel S, Lopes VHG, Batemarchi MV, Takaoka DT, Neitzert E : High levels of false positive reaction for Trypanosoma cruzi antibodies tests used for blood donors screening. Transfusion 1993; 33 (suppl) Abstract S155: 41S.
162. Carvalho MR, Krieger MA, Almeida E, Oelemann W, Shikanai-Yasuda MA, Ferreira AW, Pereira JB, Sáez-Alquézar A, Dorlhiac-Llacer PE, Chamone DP, Goldenberg S : Chagas' disease diagnosis : evaluation of several tests in blood bank screening. Transfusion 1993; 33: 830-834.
163. Ferreira AW, Belem ZR, Moura MEG, Camargo ME : Aspectos da padronização de testes sorológicos para a Doença de Chagas : Um teste imunoenzimático para a triagem de doadores de sangue. Rev Inst Med Trop S Paulo 1991; 33: 123-128.
164. Brashear RJ, Winkler MA, Schur JD, Lee H, Burczak JD, Hall HJ, Pan AA : Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I - Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi. Transfusion 1995; 35: 213-218.
165. Houghton RL, Benson D, Skeiky Y, Sleath P, Lodes M, Badaró R, Krettli A, Reed SG: Multi-epitope peptide elisa for detection of serum antibodies to Trypanosoma cruzi in patients with treated and untreated Chagas'disease. Transfusion 1996; 36 (suppl) : S137.
166. Hoffman A, Jaczko B, Jones J, Tursi N, Lee SR : Evaluation of a prototype screening ELISA and supplemental analysis for the serological identification of Chagas disease. Transfusion 1997; 37 (suppl): S181.
167. Luquetti AO: Use of Trypanosoma cruzi defined proteins for diagnosis. Multicentre trial, serological and technical aspects. Mem Inst Oswaldo Cruz 1990; 85: 497-505.
168. Zicker F, Smith PG, Luquetti AO, Oliveira OS : Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and hemagglutination tests on serum samples and on blood eluates from filter paper. Bull WHO 1990; 68: 465-471.
169. Andrade ALSS, Martelli CMT, Luquetti AO, Oliveira OS, Silva SA, Zicker F: Serologic screening for Trypanosoma cruzi among blood donors in central Brazil. Bull Pan Am Health Organ 1992; 26: 157-164.
170. Fife Jr EH, Mushel LH : Fluorescent antibody technique for serodiagnosis of Trypanosoma cruzi infection. Proc Soc Exp Biol (NY) 1959; 101: 540-543.
171. Camargo ME, Souza SL : The use of filter paper blood smears in a practical fluorescent test for American trypanosomiasis serodiagnosis. Rev Inst Med Trop S Paulo 1966; 8: 255-258.
172. Lal RB, Ottesen EA : Phosphocoline epitopes on helminth and protozoal parasites and their presence in the circulation of infected human patients. Trans Roy Soc Trop Med Hug 1989; 83: 652-655.
173. Lanar DE, Manning JE : Major surface proteins and antigens on the different in vivo and in vitro forms of Trypanosoma cruzi. Mol Biochem Paras 1984; 11: 119-131.
174. Rosfjord EC, Mikhael KS, Rowland EC, Powell MR: Analysis of antibody cross-reactivity in experimental American trypanosomiasis. J Parasital 1990; 76: 698-702.
175. Chiller TM, Samudio MA, Zoulek G : IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis. Am J Trop Med Hyg 1990; 43: 650-656.
176. Malchiodi EL, Chiaramonte MG, Taranto NJ, Zwirner NW, Margni RA : Cross reactivity studies and differential serodiagnosis of human infections caused by Trypanososma cruzi and Leishmania spp ; use of immunoblotting and Elisa with purified antigen (Ag 163B6). Cin Exp Immunol 1994; 97: 417-423.
177. Reed SG, Badaró R, Lloyd RMC : Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera. J Immunol 1987; 138: 1598-1601.
178. Sabino EC, Salles N, Stoops E, Santos ML, Saez-Alquezar A : Evaluation of Chagas Innolia assay as a confirmatory test for Chagas disease. Mem Inst Oswaldo Cruz 1997; 92: Suppl 1, 266.
179. Costa GCV, Teixeira MGM, Borges-Pereira J, Castro JAF, Coura JR, Vanderborght BOM, Stroops E, Zrein M, Peralta JM, Oelemann WMR: A recombinant antigen and peptide line immunoassay (LIA) as na alternative diagnostic test for
180. Almeida IC, Ferguson MAJ, Schenkman S, Travassos LR: Lyric anti-alpha-galactosyl antibodies from patients with chronic Chagas disease recognise novel O-linked oligosaccharides on mucin-like GPI-anchored glycoproteins of Trypanosoma cruzi. Biochem J 1994; 304: 793-802.
181. Almeida IC, Covas DT, Soussumi LMT, Travassos LR : A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 1997; 37: 850-857.
182. Umezawa E, Nascimento NS, Kasper NJR, Coura JR, Borges-Pereira J, Junqueira AC, Camargo ME : Immunoblot assay using excreted-secreted antigen of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas disease. J Clin Microbiol 1996; 34: 2143-2147.
183. Silveira-Lacerda EP, Silva AG, Junior SF, Souza MA, Kesper N, Botelho-Filho A, Umezawa ES : Chagas'disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. Vox Sang 2004; 87: 204-207.
184. Kesper N, Almeida KA, Stolf MS, Umezawa ES : Immunoblot analysis of trypomastigote excreted-secreted antigens as a tool for characterization of T. cruzi strains and isolates. J Parasital 2000; 86: 862-867.
185. Winkler MA, Brashear RJ, Hall HJ, Schur JD, Pan AA : Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II - Evaluation of a supplemental enzyme immunoassay and radioimmuneprecipitation assay for confirmation of seroreactivity. Transfusion 1995; 35: 219-225.
186. Kirchhoff LV, Gam AA, Gusmão RA, Goldsmith RS, Rezende JM, Rassi A: Increased specificity of serodiagnosis of Chagas'disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987; 155: 561-564.
187. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA: Serologic testing for Trypanosoma cruzi : comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hamagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000; 38: 639-642.
188. Wendel S, Yasuda MAS, Silva GR, Leiby DA, Umezawa E, Almeida I : Confirmatory serological methods for T. cruzi antibodies screening tests: should they be considered as imperfect gold standards? Transfusion 2005; Suppl Abstract S49-030J.
189. Zhou XH, Obuchowski NA, McClish DK : Statistical Methods in Diagnostic Medicine. New York, John Wiley & Sons, 2002.
190. Skrabalo Z, Deanovic Z : Piroplasmosis in man : report of a case. Doc Med Geogr Trop 1957; 9:11-16.
191. Scholtens RG, Braff EH, Healy GR, Gleason N : A case of babesiosis in man in the United States. Am J Trop Med Hyg 1968; 17: 810-813.
192. Homer MJ, Aguilar-Delfin I, Telford SR, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev 2000; 13: 451-469.
193. Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS : Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev 2003; 16: 622-636.
194. Meer-Scherrer L, Adelson M, Mordechai E, Lattaz B, Tilton R: Babesia microti infection in Europe. Curr Microbiol 2004; 48: 435-437.
195. Saito-Ito A, Tsuji M, Wei Q, He S, Matsui T, Kohsaki M, Arai S, Kamiyama T, Hioki K, Ishihara C : Transfusion-acquired, autochthonous human babesiosis in Japan : Isolation of Babesia microti-like parasite with hu-RBC-SCID mice. J Clin Microbiol 2000; 38: 4511-4516.
196. Shih CM, Liu LP, Chung WC, Ong SJ, Wang CC : Human babesiosis in Taiwan : asymptomatic infection with a Babesia microti-like organism in a Taiwanese women. J Clin Microbiol 1997; 35: 450-454.
197. Michael SA, Morsy TA, Montasser MF : A case of human babesiosis (preliminary case report in Egypt). J Egypt Soc Parasital 1987; 17: 409-410.
198. Bush JB, Isaäcson M, Mohamed AS, Potgieter FT, de Waal DT: Human babesiosis - a preliminary report of 2 suspected cases in southern Africa. S Afr Med J 1990; 78: 699.
199. Herwaldt BL, Cacciò S, Gherlinzoni F, Aspock H, Slemenda SB, Piccaluga P, Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S, Loschenberger K, Tura S, Pieniazek NJ : Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 2003; 9: 942-948.
200. Popovsky MA, Lindberg LE, Syrek AL, Page PL : Prevalence of Babesia antibody in a selected blood donor population. Transfusion 1988; 28: 59-61.
201. Linden JV, Wong SJ, Chu FK, Schmidt GB, Bianco C : Transfusion-associated transmission of babesiosis in New York State. Transfusion 2000; 40: 285-289.
202. Hunfeld KP, Allwinn R, Peters S, Kraiczy P, Brade V : Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from Midwestern Germany. Wien Klin Wochenschr 1998; 119: 901-908.
203. Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, Tenter AM : Seroprevalence of Babesia infections in humans exposed to ticks in Midwestern Germany. J Clin Microbiol 2002; 40: 2431-2436.
204. Herwaldt BL, McGovern PC, Gerwel MP, Easton RM, MacGregor RR : Endemic babesiosis in another eastern state : New Jersey. Emerg Infect Dis 2003; 9: 184-188.
205. Lodes MJ, Houghton RL, Bruinsma ES, Mohamath R, Reynolds LD, Benson DR, Krause PJ, Reed SG, Persing DH: Serologic expression cloning of novel immunoreactive antigens of Babesia microti. Infect Immun 2000; 68: 2783-2790.
206. Krause PJ, Spielman A, Telford SR, Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH : Persistent parasitemia acute babesiosis. N Engl J Med 1998; 339: 160-164.
207. Leiby DA, Gill JE : Transfusion-transmitted tick-borne infections : a cornucopia of threats. Transfusion Med Rev 2004; 18: 293-306.
208. Reddy RL, Delmasso AP : Transfusion acquired babesiosis in Minnesota. XXIst Congress, International Society of Blood Transfusion (ISBT)/AABB, Los Angeles, USA, 1990, Abstract S447, pp 112.
209. Mintz ED, Anderson JF, Cable RG, Hadler JL : Transfusion-transmitted babesiosis : a case report from a new endemic area. Transfusion 1991; 31: 365-368.
210. Jassoum SB, Fong IW, Hannach B, Kain KC: Transfusion-transmitted babesiosis in Ontario: first reported case in Canada. Can Commun Dis Rep 2000; 26: 9-13.
211. Eberhard ML, Walker EM, Steurer FJ : Survival and infectivity of Babesia in blood maintained at 25 C and 2-4 C. J Parasitol 1995; 81: 790-792.
212. Gerber MA, Shapiro ED, Krause PJ, Cable RG, Badon SJ, Ryan RW : The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Inf Dis 1994; 170: 231-234.
213. Montoya JG, Liesenfeld O : Toxoplasmosis. Lancet 2004; 363: 1965-1976.
214. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R : Mother-to-child transmission of toxoplasmosis : risk estimates for clinical counseling. Lancet 1999; 353: 1829-1833.
215. Rynin FW, McLeod R, Maddox JC, Hunt S, Remington JS : Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med 1979; 90: 47-49.
216. Siegel SE, Lunde MN, Gelderman AH, Halterman RH, Brown JA, Levine AS, Graw RG. Transmission of toxoplasmosis by leukocyte transfusion. Blood 1971; 37: 388-394.
217. Beauvais B, Garin JF, Lariviere M, Languillat G, Galal H : Toxoplasmose et transfusion. Ann Parasitol Hum Comp 1976; 51: 625-635.
218. Räisänen S : Toxoplasmosis transmitted by blood transfuions. Transfusion 1978; 18: 329-332.
219. Roth JA, Siegel SE, Levine AS, Berard CW : Fatal recurrent toxoplasmosis in a patient initially infected via a leukocyte transfusion. A J C P 1970; 56: 601-605.
220. Talice RV, Gurri J, Royal J, Perez-Moreira L : Investigaciones sobre la Toxoplasma gondii en sangre destinado a transfusion. Ann Fac Med Univers, Montevideo 1957; 42: 143-147.
221. Nelson JC, Kauffmann JH, Ciavarella D, Senisi WJ: Acquired toxoplasmic retinochoroiditis after platelet transfusions. Ann Ophtamol 1989; 21: 253-254.
222. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB : Toxoplasma gondii infection in the United States : seroprevalence and risk factors. Am J Epidemiol 2001; 154: 357-365.
223. Galván-Ramírez ML, Covarrubias X, Rodriguez R, Troyo R, Alfaro N : Toxoplasma gondii antibodies in Mexican blood donors. Transfusion 2005; 45: 281-282.
224. Remington JS, Thulliez P, Montoya JG : Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004; 42: 941-945.
225. Burg JL, Grover CM, Pouletty P, Boothroyd JC : Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989 27; 1787-1792.
226. Homan WL, Vercammen M, De Braekeleer J, Vershueren H : Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol 2000; 30: 69-75.
227. Costa JM, Pautas C, Ernault P, Foulet F, Cordonnier C, Bretagne S : Real-time PCR for diagnosis and follow-up of toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000; 38: 2929-2932.
228. Walton BC, Benchoff BM, Brooks WH : Comparison of the indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii. Am J Trop Med Hyg 1966; 15: 149-152.
229. Balsari A, Poli G, Molina V, Dovis M, Petruzzelli E, Boniolo A, Rollen E : ELISA for toxoplasma antibody detection : a comparison with other serodiagnostic tests. J Clin Pathol 1980; 33: 640-643.
230. Remington JS, Araujo FG, Desmonts G : Recognition of different Toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newboms. J Infect Dis 152: 1020-1024.
231. Hedman K, Lappatainen M, Seppala I, Makela O : Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989; 159: 736-739.
232. Liesendfeld O, Montoya JG, Kinney S, Press C, Remington JS : Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women : experience in a US reference laboratory. J Infect Dis 2001; 183: 1248-1253.
233. McDonald CP, Barbara JAJ, Contreras M, Brown S : Provision of a panel of Anti-Toxoplasma-Negative blood donors. Vox Sang 1989; 57: 55-58.
234. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
235. Chung HL, Chow KK, Lu JP : The first two cases of transfusion Kala-azar. Chin Med J 1948; 66: 325-326.
236. Andre R, Brumpt L, Dreyfus B : Cutaneous leishmaniasis, cutaneous glandular leishmaniasis and trasfusional Kala-azar. Trop Dis Bull 1958; 55: 379.
237. Kostman R, Barr M, Bengtssom E, Garnham PCC, Huit G : Kala-azar transferred by exchange blood transfusion in two Swedish infants. Proceeding of the Seventh International Congress of Tropical Medicine and Malaria, 1963, vol 2, 384p.
238. Anonymous : Defense Department drops question on leishmaniasis for blood donor. Blood Bank Week 1993; 10 (45): 4-5. http://www.pdhealth.mil/downloads/ Leishmaniasis_Information_28%20April%2005.pdf.